A Clinical Case of Autoimmune Hepatitis Type 1 in a Patient Aged 10 Years
https://doi.org/10.31550/1727-2378-2023-22-7-58-61
Abstract
Aim. To demonstrate a clinical case of autoimmune hepatitis type 1 in a patient aged 10 years.
Key points. Certain infections can cause frequently asymptomatic and self-limited hepatitis, while others may result to severe acute hepatitis and/or act as a trigger for autoimmune hepatitis in young children. We present the case of a previously healthy 10-year-old girl with a syndrome of cytolysis and cholestasis who had elevated serum transaminases, Epstein — Barr virus (EBV) serology compatible with recent EBV infection, and positive anti-smooth muscle antibody characteristic of onset autoimmune hepatitis type 1. Liver biopsy was also typical of autoimmune hepatitis as attested by the presence of portal inflammation and interface hepatitis. Persistent EBV-related hepatitis was excluded by negative serum EBV-PCR.
Conclusion. The presented clinical case suggests that in children with cholestatic hepatitis, positive EBV serology cannot exclude the presence of other causes of liver disease. In this context, autoimmune hepatitis should be considered as an alternate diagnosis, particularly when there is specific liver-related autoantibody detection. In such conditions, a liver biopsy seems mandatory to achieve a correct and on-time diagnosis of a poor prognostic disease such as autoimmune hepatitis.
About the Authors
O. A. Asatryan
Yerevan State Medical University named after Mkhitar Heratsi
Armenia
Armenia
2 Koryun Str., Yerevan, 0025
K. G. Simonyan
Yerevan State Medical University named after Mkhitar Heratsi
Armenia
Armenia
2 Koryun Str., Yerevan, 0025
Hr. V. Apresyan
Yerevan State Medical University named after Mkhitar Heratsi
Armenia
Armenia
2 Koryun Str., Yerevan, 0025
T. V. Sargsyan
Yerevan State Medical University named after Mkhitar Heratsi
Armenia
Armenia
2 Koryun Str., Yerevan, 0025
N. R. Hovhannisyan
Yerevan State Medical University named after Mkhitar Heratsi
Armenia
Armenia
2 Koryun Str., Yerevan, 0025
References
1. Larson-Nath C., Vitola B. Pediatric acute liver failure. Crit. Care Clin. 2022;38(2):301–15. DOI: 10.1016/j.ccc.2021.11.015
2. Quirós E., Piédrola G., Maroto C. GB virus C in patients with liver disease of unknown etiology. J. Clin. Lab. Anal. 2000;14(2):70–2. DOI: 10.1002/(SICI)1098-2825(2000)14:2<70::AID-JCLA6>3.0.CO;2-M
3. Chiou F.K., Logarajah V., Ho C.W.W., Goh L.S. et al. Demographics, aetiology and outcome of paediatric acute liver failure in Singapore. Singapore Med. J. 2022;63(11):659–66. DOI: 10.11622/smedj.2021138
4. Narkewicz M.R., Dell Olio D., Karpen S.J., Murray K.F. et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J. Pediatr. 2009;155(6):801–6.e1. DOI: 10.1016/j.jpeds.2009.06.005
5. Raimondo G., Locarnini S., Pollicino T., Levrero M. et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J. Hepatol. 2019;71(2):397–408. DOI: 10.1016/j.jhep.2019.03.034
6. Mrzljak A., Tabain I., Premac H., Bogdanic M. et al. The role of emerging and neglected viruses in the etiology of hepatitis. Curr. Infect. Dis. Rep. 2019;21(12):51. DOI: 10.1007/s11908-019-0709-2
7. Styczynski J., Czyzewski K., Wysocki M., Gryniewicz-Kwiatkowska O. et al. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. Clin. Microbiol. Infect. 2016;22(2):179.e1–10. DOI: 10.1016/j.cmi.2015.10.017
8. Pelland-Marcotte M.C., Hwee J., Pole J.D., Nathan P.C. et al. Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature. Leuk. Lymphoma. 2019;60(9):2104–14. DOI: 10.1080/10428194.2019.1573369
9. Shaukat A., Tsai H.T., Rutherford R., Anania F.A. Epstein — Barr virus induced hepatitis: an important cause of cholestasis. Hepatol. Res. 2005;33(1):24–6. DOI: 10.1016/j.hepres.2005.06.005
10. Niller H.H., Wolf H., Minarovits J. Regulation and dysregulation of Epstein — Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity. 2008;41(4):298–328. DOI: 10.1080/08916930802024772
11. Vento S., Cainelli F. Is there a role for viruses in triggering autoimmune hepatitis? Autoimmun. Rev. 2004;3(1):61–9. DOI: 10.1016/S1568-9972(03)00053-3
12. Hennes E.M., Zeniya M., Czaja A.J., Parés A. et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–76. DOI: 10.1002/hep.22322
13. Zachou K., Gatselis N., Papadamou G., Rigopoulou E.I. et al. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. J. Hepatol. 2011;55(3):636–46. DOI: 10.1016/j.jhep.2010.12.032
14. Mieli-Vergani G., Heller S., Jara P., Vergani D. et al. Autoimmune hepatitis. J. Pediatr. Gastroenterol. Nutr. 2009;9(2):158–64. DOI: 10.1097/MPG.0b013e3181a1c265
15. Papamichalis P.A., Zachou K., Koukoulis G.K., Veloni A. et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J. Autoimmune Dis. 2007;29(4):3. DOI: 10.1186/1740-2557-4-3
16. Gatselis N.K., Zachou K., Papamichalis P., Koukoulis G.K. et al. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig. Liver Dis. 2010;42(11):807–12. DOI: 10.1016/j.dld.2010.03.005
17. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L. et al. International Autoimmune Hepatitis Group Report: review criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999;31(5):929–38. DOI: 10.1016/s0168-8278(99)80297-9
18. Vento S., Guella L., Mirandola F., Cainelli F. et al. Epstein — Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet. 1995;346(8975):608–9. DOI: 10.1016/s0140-6736(95)91438-2
19. Cabibi D. Autoimmune hepatitis following Epstein — Barr virus infection. BMJ Case Rep. 2008;2008:bcr0620080071. DOI: 10.1136/bcr.06.2008.0071
20. Nakajima S., Umebayashi H., Kurosawa R., Imagawa T. et al. A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(3):154–8. DOI: 10.2177/jsci.28.154
Review
For citations:
Asatryan O.A., Simonyan K.G., Apresyan H.V., Sargsyan T.V., Hovhannisyan N.R. A Clinical Case of Autoimmune Hepatitis Type 1 in a Patient Aged 10 Years. Title. 2023;22(7):58-61. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-7-58-61
Views:
15
Email this article 